Pharmabiz5h
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS: Copenhagen, Denmark Wednesday, October 9, 20 ...
Pharmabiz6h
NIHR and the Office for Life Sciences fund new projects to drive earlier diagnosis of cancer
The NIHR and the Office for Life Sciences (OLS) have funded six projects through NIHR's Invention for Innovation (i4i) and the OLS Cancer Programme. These six projects are receiving almost £11 million ...
Pharmabiz7h
Ascentage Pharma gets China NMPA nod to start registrational phase III studies of APG-2449 to for treat patients with NSCLC
Rockville, Maryland Wednesday, October 9, 2024, 16:00 Hrs [IST] ...
Pharmabiz8h
ModeX Therapeutics secures $35 mn BARDA supplement to develop Covid multispecific antibodies and $16 mn to initiate influenza programme
Weston, Massachusetts Wednesday, October 9, 2024, 15:00 Hrs [IST] ...
Pharmabiz9h
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy
Philips and Siloam Hospitals sign AI capability MoU to support Indonesia’s healthcare transformation strategy: Jakarta, Indonesia Wednesday, October 9, 2024, 14:30 Hrs [IST] Roy ...
Pharmabiz9h
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting: London, UK Wednesday, October 9, 2024, 14:0 ...
Pharmabiz11h
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...
Pharmabiz12h
Merck’s phase 3 KEYNOTE-689 trial of anti-PD-1 therapy, Keytruda to treat LA-HNSCC meets its primary endpoint of event-free survival
Rahway, New Jersey Wednesday, October 9, 2024, 11:00 Hrs [IST] ...
Pharmabiz13h
US FDA grants marketing authorization to Healgen Rapid Check Covid-19/Flu A&B antigen test
US FDA grants marketing authorization to Healgen Rapid Check Covid-19/Flu A&B antigen test: Maryland Wednesday, October 9, 2024, 10:00 Hrs [IST] The US Food and Drug Administratio ...
Pharmabiz14h
Boehringer gets US FDA breakthrough therapy designation and initiates two phase III trials in MASH for survodutide
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health., announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for ...
Pharmabiz15h
SA Ramesh has been elected president of TNCDA; KK Selvan secretary
SA Ramesh has been elected president of TNCDA; KK Selvan secretary: Peethaambaran Kunnathoor, Chennai Wednesday, October 9, ...
Pharmabiz15h
Karnataka's GCC policy strengthens its ecosystem for drug and medical device product conceptualization
Karnataka's GCC policy strengthens its ecosystem for drug and medical device product conceptualization: Nandita Vijayasimha, Bengaluru Wednesday, October 9, 2024, 08:00 Hrs [IST] ...